EBM Technologies Incorporated (TPEX:8409)
Taiwan
· Delayed Price · Currency is TWD 22.00
+0.35 (1.62%)
May 2, 2025, 10:40 AM CST
EBM Technologies Revenue
In the year 2024, EBM Technologies had annual revenue of 280.95M TWD with 36.29% growth. EBM Technologies had revenue of 178.04M in the quarter ending December 31, 2024, with 82.90% growth.
Revenue
280.95M
Revenue Growth
+36.29%
P/S Ratio
2.47
Revenue / Employee
n/a
Employees
n/a
Market Cap
692.80M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 280.95M | 74.81M | 36.29% |
| Dec 31, 2023 | 206.15M | -177.74M | -46.30% |
| Dec 31, 2022 | 383.88M | 188.95M | 96.93% |
| Dec 31, 2021 | 194.93M | -20.40M | -9.47% |
| Dec 31, 2020 | 215.34M | -19.31M | -8.23% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Oneness Biotech | 117.93M |
| Polaris Group | 107.00M |
| Pegavision | 6.82B |
| Lumosa Therapeutics | 39.15M |